JW Asset Management’s Pharming Group PHAR Stock Holding History

JW Asset Management’s Portfolio PHAR Stock Details PHAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-169,225	Closed	-$1.91M	–	10
2021 Q2	$1.91M	Sell	169,225 -20,368	-11%	-$254K	0.45%	5
2021 Q1	$2.43M	Sell	189,593 -1,706,348	-90%	-$23.8M	0.7%	6
2020 Q4	$2.95M	Buy	+1,895,941	New	+$29M	1.21%	5

Other funds holding PHAR

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

CPA

Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JW Asset Management's PHAR Position: Q3 2021 in Review

JW Asset Management sold out of Pharming Group (PHAR) in Q3 2021, closing a stake of 169,225 shares — an estimated $1.91M sold.

JW Asset Management first reported a position in PHAR in Q4 2020 and held it in 3 quarters. The position peaked at $2.95M in Q4 2020. 4 funds tracked by Wall St. Rank hold PHAR as of Q3 2021.

JW Asset Management reported no remaining Pharming Group position as of Q3 2021 after selling out during the quarter.
JW Asset Management sold 169,225 Pharming Group shares in Q3 2021, an estimated $1.91M.
JW Asset Management first reported a position in Pharming Group in Q4 2020 and held it in 3 quarters.
JW Asset Management's Pharming Group position peaked at $2.95M in Q4 2020.
4 funds tracked by Wall St. Rank held Pharming Group as of Q3 2021.

Based on JW Asset Management's 13F filing for Q3 2021, filed 5 Nov 2021.